Building a diagnostic kit for complement deficiencies starts with the right immunoassay raw materials—and the right format to match your target analyte.
For C3, C4, and C1 Inhibitor (C1 INH), you need high-affinity monospecific antibodies, calibrator-grade purified antigens, and reliable detection labels. The most common methods are sandwich ELISA, nephelometry, and radial immunodiffusion (RID), each using these core components to yield quantitative results from serum samples.
The central challenge is not just detecting these proteins but doing so across their enormous physiological concentration differences. A robust kit must pair antibodies and calibrators that deliver a wide dynamic range for abundant targets like C3 while maintaining the functional specificity needed to spot latent C1 INH defects. Immunoassays measure protein mass, not functionality—so a complete HANE panel still requires a functional complement.
The Core Raw Materials for Complement Immunoassays
Every quantitative diagnostic kit for complement proteins revolves around three building blocks: the capture/detection binder, the standard for quantification, and the signal-generating molecule.
High‑Affinity Monospecific Antibodies
The analytical heart of any immunoassay is the antibody pair. You need monospecific anti‑C3, anti‑C4, and anti‑C1 INH antibodies that recognize their target without cross‑reacting with other complement components or plasma proteins.
For sandwich formats, a matched pair—a capture antibody and a detection antibody, often binding to distinct epitopes—is ideal.
Affinity should be in the picomolar to low nanomolar range ((K_d = 10^{-8}) to (10^{-11} \text{ M})) to reliably capture analytes even at low concentrations or when the protein is partially consumed.
Purified Calibrator Antigens
Quantitation requires a standard curve built from highly purified, accurately assigned calibrators.
Recombinant C3, C4, and C1 INH expressed in mammalian or insect systems offer batch‑to‑batch consistency and avoid the biological variability of plasma‑derived material.
Calibrator concentrations must be traceable to an international reference preparation, such as the WHO standard for human complement proteins.
Because C3 circulates at 1,000–1,500 µg/mL and C4 at 300–600 µg/mL, your calibrators must cover a broad dynamic range—often requiring serial dilutions that span three or more orders of magnitude.
Labeled Tracers and Detection Systems
The detection reagent is typically a secondary antibody or a detection antibody directly conjugated to an enzyme, fluorophore, or chemiluminescent molecule.
Common choices include horseradish peroxidase (HRP) and alkaline phosphatase (AP) for colorimetric or chemiluminescent readouts, and acridinium esters for high‑sensitivity chemiluminescence in automated platforms.
Stability of the labeled tracer is critical—any degradation shifts the standard curve and erodes lot‑to‑lot consistency.
Selecting the Right Immunoassay Method
The same raw materials can be deployed in different assay architectures. Your choice depends on throughput, sensitivity, and the physiological concentration of the target.
Sandwich ELISA for High Sensitivity and Specificity
Sandwich ELISA is the workhorse for complement protein quantification.
A capture antibody is coated onto a microplate; after sample incubation and washing, a labeled detection antibody generates signal proportional to analyte concentration.
This format excels for C3, C4, and C1 INH because their serum concentrations are easily detected above the background after appropriate dilution—typically 1:1,000 to 1:50,000 for C3, and 1:200 to 1:2,000 for C4 and C1 INH.
Nephelometry for High‑Throughput Automated Labs
Nephelometry measures the light scatter of antibody‑antigen complexes in solution.
It’s widely used on clinical chemistry analyzers for C3 and C4 because it requires minimal sample handling and delivers rapid results.
The raw material demand is the same—specific antisera or purified antibodies—but you trade some absolute sensitivity for speed and full automation. Nephelometry is less common for C1 INH due to potential interference from lipid or haemoglobulin in samples.
Radial Immunodiffusion (RID) for Simplicity
RID embeds antibody in an agarose gel; antigen diffuses radially, forming a precipitin ring whose diameter correlates with concentration.
Although low‑throughput and slower than ELISA, RID uses the same antisera and is still employed when electricity‑free, low‑cost testing is needed.
It remains a viable format for C3 and C4 in resource‑limited settings.
Competitive Formats for Low‑Abundance or Small Targets
While C3, C4, and C1 INH are high‑abundance proteins, some complement components (like Factor D at ~2 µg/mL) demand a competitive format to achieve low‑end sensitivity.
If your kit must also measure a low‑abundance regulatory protein, you will need a high‑affinity primary antibody, a labelled tracer, and a separation reagent (e.g., PEG or a species‑specific secondary antibody) to isolate bound complexes.
For high‑abundance proteins, a competitive format is rarely necessary and often simpler sandwich methods are preferred.
Understanding the Trade‑Offs
No single design solves every problem. Recognizing the inherent limitations lets you engineer a kit that truly serves the clinic.
Sensitivity vs. Dynamic Range
C3’s enormous serum concentration forces a compromise.
If you optimise for sensitivity to detect low‑level consumption, you lose the upper linear range; if you aim for a wide dynamic range, you may sacrifice precision at the low end.
The solution is often a two‑point dilution protocol—one high dilution for normal/high samples, a lower one for suspected deficiencies—backed by calibrators that span 0.5 to >2,000 µg/mL.
Antigenic Detection vs. Functional Capacity
An immunoassay measures protein mass, not biological activity.
In type II HANE, C1 INH protein levels are normal or even elevated, but the molecule is dysfunctional due to a mutation.
A C1 INH ELISA alone will miss these patients. Always pair a quantitative C1 INH ELISA with a functional C1‑esterase inhibitor assay (e.g., chromogenic C1s inhibition) to detect such defects.
Similarly, low C3 and C4 can indicate consumption (as in SLE) or a rare genetic deficiency; combining immunoassay results with a CH50 functional screen resolves this ambiguity.
Antibody Cross‑Reactivity and Lot‑to‑Lot Consistency
Polyclonal antisera against C3 may cross‑react with iC3b or C3d, the breakdown products that accumulate during inflammation.
If your goal is to measure native C3 consumption, you need a monoclonal antibody specific for the intact, un‑cleaved molecule—or design an assay that differentiates the two.
All raw materials—antibodies, calibrators, and tracers—require rigorous lot‑to‑lot equivalency testing. Even minor shifts in affinity or purity can alter clinical cutoff values.
How to Apply This to Your Diagnostic Kit Development
The right raw materials and format depend directly on the clinical question your kit is solving. Tailor your approach accordingly.
- If your primary focus is a screening panel for systemic lupus or immune complex disease: Build a sandwich ELISA or nephelometric assay for C3 and C4 using high‑dilution protocols. Combine with a CH50 functional reagent to distinguish consumption from genetic deficiency.
- If your primary focus is diagnosing hereditary angioedema: Design a C1 INH quantitative immunoassay (sandwich ELISA or nephelometry) but always include a C1 INH functional assay. The raw material investment must cover both the protein‑level kit and a functional substrate (e.g., C1s and a chromogenic peptide).
- If your primary focus is a low‑cost, manual‑lab kit: Radial immunodiffusion plates with monospecific antisera for C3 and C4 provide a robust, electricity‑free option, though they lack the precision of automated methods.
- If your goal is to build a complete complement deficiency panel: You will need both functional pathway screening reagents (CH50, AH50) and quantitative immunoassays for individual components. Start with the high‑abundance markers (C3, C4) and the regulatory protein C1 INH, then expand to low‑abundance components using high‑affinity antibodies and competitive formats where needed.
Understanding the raw material requirements is only the beginning; success comes from pairing the right immunological detection with the functional context that each complement protein demands.
Summary Table:
| Assay Method | Core Raw Materials | Typical Sample Dilution | Key Strengths | Primary Limitations |
|---|---|---|---|---|
| Sandwich ELISA | Matched antibody pairs, purified calibrators, enzyme/fluorophore tracers | 1:1,000–1:50,000 (C3); 1:200–1:2,000 (C4/C1 INH) | High sensitivity, wide dynamic range, reliable quantitation | Multi-step incubation and washing required |
| Nephelometry | Specific antisera or monospecific antibodies | Automated dilution on clinical analyzers | High throughput, fully automated, rapid results | Sample turbidity (lipids/hemolysis) can interfere |
| Radial Immunodiffusion (RID) | Monospecific antisera in agarose gels | Direct / minimal manual sample prep | Low cost, simple, requires no specialized electronics | Low throughput, slow turnaround, manual readout |
Accelerate Your Complement Diagnostic Development with CamelBio
Building robust, clinical-grade complement assays requires premium components and precise lot-to-lot consistency. CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to high-quality IVD raw materials, technical services, and consulting—covering every stage from concept to clinic.
Whether you need high-affinity monospecific antibodies, calibrator-grade antigens, or expert protocol optimization, our team is here to support your pipeline.
Contact CamelBio today to request raw material samples or discuss your diagnostic kit development needs!